SR One

Biotechnology · Venture Capital

Facts

as of Nov 17, 2026

SR One is a venture capital firm investing in biotechnology and life sciences companies developing transformative medicines. It backs companies from early to late stage across therapeutic modalities, working with founders in the United States and Europe to build and scale drug development businesses. Originally established in 1985 as the corporate venture arm of GSK, SR One became an independent firm in 2020 and is based in Philadelphia with offices in the San Francisco Bay Area and London.

Headquarters
Philadelphia, United States
Founded
1985
Website
srone.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Philadelphia United StatesHeadquarters0
Source: office addresses in postings and company registers

Newsroom

top 2%Web presenceof 133.2M domains by links, Common Crawl
Sources: the outlets named on each headline, each story once